Measles is back in the US, spurring new drug development
news · 2026-07-27 · Wired Science
Measles cases in the US are at a multi-decade high, forcing researchers to fast-track drug development for a disease once considered eradicated. This means new treatments could soon be available for vulnerable populations and those who contract the highly contagious virus, shifting focus from prevention to active treatment.
Sabin's take. Remember measles? Yeah, it's not a dusty history lesson anymore. The US is seeing a surge in cases not seen in decades, which means vaccine rates are, well, not where they should be. Now, instead of just pushing preventative measures, scientists are developing actual drugs to treat the virus. This isn't just about measles; it's a stark reminder that our collective immunity needs constant work. When a disease like measles, known for its ability to wipe the immune system's memory, starts popping up again, it's a giant red flag for overall public health. Watch for more conversations around herd immunity failures and the push-pull between individual choice and community health. Your nervous system is probably already stressed imagining this, and for good reason.
#policy #research #immunity #nervous-system #public-health